Suppr超能文献

培养的人内皮细胞合成血管性血友病因子。

Synthesis of von Willebrand factor by cultured human endothelial cells.

作者信息

Jaffe E A, Hoyer L W, Nachman R L

出版信息

Proc Natl Acad Sci U S A. 1974 May;71(5):1906-9. doi: 10.1073/pnas.71.5.1906.

Abstract

Cultured human endothelial cells synthesize and secrete a protein(s) which has Factor VIII antigen but which lacks Factor VIII clot-promoting activity (J. Clin. Invest. 52, 2757-2764, 1973). Von Willebrand factor activity has been identified in medium from cultured human endothelial cells. This activity was demonstrated by the ability to correct the defect in platelet adhesiveness of blood obtained from patients with von Willebrand's disease. This activity also supported ristocetin-induced aggregation of washed normal human platelets. The von Willebrand factor activity from cultured endothelial cells has physicochemical and immunologic properties like those of the von Willebrand factor activity and the Factor VIII antigen present in human plasma and the Factor VIII antigen synthesized by human endothelial cells in vitro. Rabbit antibody to chromatographic fractions containing endothelial cell von Willebrand factor inhibits the platelet retention of normal blood in glass bead columns.

摘要

培养的人内皮细胞合成并分泌一种具有因子VIII抗原但缺乏因子VIII促凝活性的蛋白质(《临床研究杂志》52, 2757 - 2764, 1973)。在培养的人内皮细胞培养基中已鉴定出血管性血友病因子活性。这种活性通过纠正从血管性血友病患者获得的血液中血小板黏附缺陷的能力得以证明。这种活性还支持瑞斯托霉素诱导的正常人洗涤血小板聚集。培养内皮细胞的血管性血友病因子活性具有与人类血浆中存在的血管性血友病因子活性以及体外人内皮细胞合成的因子VIII抗原相同的物理化学和免疫学特性。针对含有内皮细胞血管性血友病因子的色谱级分的兔抗体可抑制正常血液在玻璃珠柱中的血小板滞留。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5841/388351/f64a6ece5b60/pnas00058-0331-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验